Want to see AVTX full AI Analyst Report?
Avalo Therapeutics (AVTX) Ownership Overview
0.70% Insiders
20.02% Mutual Funds
0.19% Other Institutional Investors
13.34% ETFs
65.74% Public Companies and
Individual Investors
The ownership structure of Avalo Therapeutics (AVTX) stock is a mix of institutional, retail, and individual investors. Approximately 33.55% of the company’s stock is owned by Institutional Investors, 0.70% is owned by Insiders, and 65.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 19, 2026 | xxxxxxxxxxxxx | $696927 | |
Aug 12, 2026 | xxxxxxxxxxxxx | $52011 | |
Mar 18, 2026 | xxxxxxxxxxxxx | $411441 | |
Nov 17, 2025 | xxxxxxxxxxxxx | $162876 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $18480000 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $4062144 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $231813 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $46163040 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,557,785 | Institution | 4.77% | 18,339,318 | |
| 2,498,000 | Institution | 4.66% | 17,910,660 | |
| 2,212,739 | Institution | 4.13% | 15,865,339 | |
| 2,052,794 | Institution | 3.83% | 14,718,533 | |
| 1,756,123 | Institution | 3.27% | 12,591,402 | |
| 1,475,681 | Institution | 2.75% | 10,580,633 | |
| 1,211,600 | Institution | 2.26% | 8,687,172 | |
| 1,000,000 | Institution | 1.86% | 7,170,000 | |
| 695,600 | Institution | 1.30% | 4,987,452 | |
| 639,700 | Institution | 1.19% | 4,586,649 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,212,739 | Institution | 4.13% | 15,865,339 | |
| 1,475,681 | Institution | 2.75% | 10,580,633 | |
| 1,211,600 | Institution | 2.26% | 8,687,172 | |
| 695,600 | Institution | 1.30% | 4,987,452 | |
| 639,700 | Institution | 1.19% | 4,586,649 | |
| 586,000 | Institution | 1.09% | 4,201,620 | |
| 506,015 | Institution | 0.94% | 3,628,128 | |
| 486,556 | Institution | 0.91% | 3,488,607 | |
| 471,822 | Institution | 0.88% | 3,382,964 | |
| 424,953 | Institution | 0.79% | 3,046,913 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,675,498 | Institution | 3.12% | 25,685,384 | |
| 1,549,249 | Institution | 2.89% | 11,030,653 | |
| 1,283,223 | Institution | 2.39% | 9,136,548 | |
| 529,094 | Institution | 0.99% | 8,111,011 | |
| 296,836 | Institution | 0.55% | 4,550,496 | |
| 246,203 | Institution | 0.46% | 1,752,965 | |
| 241,940 | Institution | 0.45% | 1,800,034 | |
| 235,966 | Institution | 0.44% | 1,680,078 | |
| 233,834 | Institution | 0.44% | 1,664,898 | |
| 154,160 | Institution | 0.29% | 1,097,619 |
FAQ
Who Owns Avalo Therapeutics (AVTX)?
According to the latest TipRanks data, approximately 0.19% of the company's stock is held by institutional investors, 0.70% is held by insiders, and 65.74% is held by retail investors.
What percentage of Avalo Therapeutics (AVTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.19% of Avalo Therapeutics (AVTX) stock is held by institutional investors.
What percentage of Avalo Therapeutics (AVTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.74% of Avalo Therapeutics (AVTX) stock is held by retail investors.
Who owns the most shares of Avalo Therapeutics (AVTX)?
Vanguard owns the most shares of Avalo Therapeutics (AVTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.